Top Pharmaceuticals stocks in North America
Manufacturers and marketers of generic and specialty drugs, as well as researchers and developers of new drugs, medical products and procedures.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
LLYEli Lilly and Co | $697.40bn | 72.86 | 0.62% |
JNJ WDJohnson & Johnson | $397.54bn | 20.6 | 2.81% |
JNJJohnson & Johnson | $352.17bn | 16.02 | 3.26% |
MRKMerck & Co | $332.33bn | 59.41 | 2.29% |
ABBVAbbvie | $282.63bn | 35.14 | 3.71% |
AMGNAmgen | $144.81bn | 21.12 | 3.16% |
PFEPfizer | $143.83bn | 7.93 | 6.46% |
CELG RTBristol-Myers Squibb Co | $90.92bn | 0.01 | 4200% |
BMYBristol-Myers Squibb Co | $90.92bn | 11.96 | 5.15% |
GILDGilead Sciences | $81.51bn | 11.73 | 4.62% |
ZTSZoetis | $72.39bn | 30.69 | 0.95% |
MCKMcKesson | $71.39bn | 24.15 | 0.41% |
BIIBBiogen | $30.42bn | 22.58 | n/a |
HZNPHorizon Therapeutics | $26.63bn | 51.44 | n/a |
CAHCardinal Health | $25.10bn | 21.67 | 1.93% |
RPRXRoyalty Pharma | $16.73bn | 11.05 | 2.86% |
BMRNBiomarin Pharmaceutical | $15.35bn | 75.64 | n/a |
VTRSViatris | $13.74bn | 21.55 | 4.15% |
INCYIncyte | $11.60bn | 18.83 | n/a |
CTLTCatalent | $10.12bn | n/a | n/a |